Anti-Myeloperoxidase antibody [EPR20257] (Ab208670)

推荐稀释比例

• IHC-P1/1000 Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
• WB1/1000
• ICC/IF1/100
• Flow Cyt (Intra)1/500

Anti-Myeloperoxidase antibody [EPR20257] (ab208670) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB. Anti-Myeloperoxidase antibody [EPR20257] (ab208670) was first used in a scientific publication in 2018 and has been cited over 162 times in peer reviewed journals. It's performance in IHC and Western Blot in mouse samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Myeloperoxidase antibody [EPR20257] (ab208670) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Myeloperoxidase antibody [EPR20257] (ab208670) has 5 independent reviews from customers. Anti-Myeloperoxidase antibody [EPR20257] (ab208670) specifically detects Myeloperoxidase (UniProt ID: P05164; Molecular weight: 79kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR20257 - ab221847. Antibody clone EPR20257 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Biotin ( ab225474, ab322301 ). - Recombinant format for unrivalled batch-batch consistency: no need for same-lot requests Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.